|CCL 08.06.25 CHI's Stucture-Based Drug Design, Boston, Massachusetts|
From: chemistry-request at ccl.net
To: chemistry-request at ccl.net
Date: Wed May 14 23:24:04 2008
Subject: 08.06.25 CHI's Stucture-Based Drug Design, Boston, Massachusetts
CHI's Stucture-Based Drug Design June 25-27, 2008 The World Trade Center, Boston, Massachusetts Advanced registration discount ends May 23. Register at http://www.healthtech.com/sbd/overview.aspx Session Topics: * Structure-Based Modeling of GPCRs * Determination of Protein-Protein Interaction Sites * Computational-Based Protein Design * Hit and Lead Optimization * Accounting for Receptor Flexibility in Ligand Binding * Challenges of Docking and Screening * Experimental Approaches * Case Studies Distinguished Faculty: * Matthew Clark, Ph.D., Senior Director of Scientific Computation, Locus Pharmaceuticals * David Dalgarno, Ph.D., Vice President, Research Technologies, ARIAD Pharmaceuticals Inc. * Stefan Geschwindner, Ph.D., Principal Scientist and Team Leader, Protein Engineering, Global Structural Chemistry, AstraZeneca R&D * Andrew Good, Ph.D., Principal Scientist, Computer Assisted Drug Design, Bristol-Myers Squibb * Andreas Gosberg, Ph.D., Senior Scientist II, Medicinal Chemistry, SGX Pharmaceuticals * Roderick E. Hubbard, Senior Fellow, Vernalis and Professor, University of York * Paul Labute, Ph.D., President, Chemical Computing Group Inc. * Jonathan S. Mason, Ph.D., Chief Scientist & Divisional Director, Computational Chemistry & Structural Biology, Lundbeck Research (Denmark) * Stephen Mayo, Ph.D., Professor of Biology and Chemistry, California Institute of Technology * Stefan Modeling, Ph.D., Head of Molecular Modeling Unit, Laboratory of Biological Modeling, NIH, NIDDK * Xavier J. Morelli, Ph.D., Principal Investigator, NMR and Drug Design, National Center for Scientific Research (CNRS) * Mark Mulvihill, Ph.D., Associate Director of Chemistry, Oncology, OSI Pharmaceuticals * Jennifer Nemeth, Ph.D., Principal Research Scientist, Protein Engineering, Centocor Research and Development * Christopher Phillips, Ph.D., Senior Principal Scientist, Exploratory Medicinal Sciences, Pfizer Global Research and Development * Alan C. Rigby Ph.D., Assistant Professor of Medicine, Harvard Medical School * Tomi Sawyer, Ph.D., Chief Scientific Officer, AILERON Therapeutics; Editor-in-Chief, Chemical Biology & Drug Design * Sharon Shacham, Ph.D., Vice President, Drug Development, EPIX Pharmaceuticals * B. Woody Sherman, Ph.D., Director, Applications Science, Schrodinger, Inc. * Lena Tagmose, Ph.D., Head of Section, Computational Chemistry, Lundbeck Research (Denmark) * Gergely Toth, Ph.D., Scientist, Computational Chemistry and Biology, Elan Pharmaceuticals * Thomas J. Tucker, Ph.D., Senior Research Fellow, Dept. of Medicinal Chemistry, Merck Research Laboratories * T. R. Vedananda, Ph.D., Program Head, Diabetes & Metabolism, Novartis * C.M. (Venkat) Venkatachalam, Ph.D., Fellow, Accelrys, Inc. * Zsolt Zsoldos, Co-Founder and CSO, SimBioSys Prior to the start of this conference will be a pre-conference workshop (Designing Kinase Inhibitors) on June 25. Visit our website for full details on the Structure-Based Drug Design conference and pre-conference workshop: http://www.healthtech.com/sbd/overview.aspx The industry has relied on CHI for many year's to deliver top-notch science and quality networking in drug design...Don't miss out! Be sure to register by May 23to receive the lowest conference registration fee. To register, visit our website, or call +1 781-972-5400 or toll-free in the U.S. 888-999-6288. Sponsorship and Exhibit Opportunities are Available: Exhibiting at this premier event allows you to showcase your expertise, brand your solutions and develop revenue-generating opportunities with qualified decision-makers. Sponsorship packages are designed to achieve your lead generation, business development and networking goals and objectives. Through your sponsorship, CHI will help your company meet these goals plus maximize exclusive sponsorship branding opportunity pre, post and while at the Structure-Based Design conference. Sponsorship features include pre-conference, at-conference and post-conference benefits providing a well-rounded marketing campaign. For details and to contract space, contact Katelin Fitzgerald at 781-972-5458 or kfitzgerald[a]healthtech.com Present a Poster: Delegates are encouraged to display their recent research and progress in structure-based design by displaying a poster. Your poster will be included in our conference CD that is distributed to all our delegates on-site. Submit a poster by June 8 and CHI will take an additional $50 off your conference registration.NOTE THAT E-MAIL ADDRESSES HAVE BEEN MODIFIED!!!
All @ signs were changed to [a] to fight spam. Before you send e-mail, you need to change [a] to @
For example: change joe[a]big123comp.com to email@example.com
Please let colleagues know about conference listingts at Computational Chemistry List Conference Page at http://www.ccl.net/chemistry/a/conferences/.
Please help: If you find this conference list useful but you noticed some conference missing, please consider including it here by using the Conference Submission Page. It is free but your support is welcome. You will help others!!!
|Modified: Thu May 15 03:24:04 2008 GMT|
|Page accessed 4195 times since Thu May 15 03:24:04 2008 GMT|
Please help maintain CCL: If you found that your conference is listed here, please consider supporting CCL as a Supporting Member or use other Paid Services of CCL to ensure the continuation of this useful service. We cannot do it without your help.